IBDEI0B3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5235,0)
 ;;=294.8^^41^483^33
 ;;^UTILITY(U,$J,358.3,5235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5235,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,5235,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,5235,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,5236,0)
 ;;=438.6^^41^483^7
 ;;^UTILITY(U,$J,358.3,5236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5236,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,5236,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,5236,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,5237,0)
 ;;=438.7^^41^483^26
 ;;^UTILITY(U,$J,358.3,5237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5237,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,5237,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,5237,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,5238,0)
 ;;=438.84^^41^483^5
 ;;^UTILITY(U,$J,358.3,5238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5238,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,5238,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,5238,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,5239,0)
 ;;=434.91^^41^483^27
 ;;^UTILITY(U,$J,358.3,5239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5239,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,5239,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,5239,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,5240,0)
 ;;=333.94^^41^483^101
 ;;^UTILITY(U,$J,358.3,5240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5240,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,5240,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,5240,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,5241,0)
 ;;=345.90^^41^483^104
 ;;^UTILITY(U,$J,358.3,5241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5241,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,5241,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,5241,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,5242,0)
 ;;=907.0^^41^483^73
 ;;^UTILITY(U,$J,358.3,5242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5242,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,5242,1,5,0)
 ;;=5^Late Effect Intracranial Injury
 ;;^UTILITY(U,$J,358.3,5242,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,5243,0)
 ;;=339.00^^41^483^43
 ;;^UTILITY(U,$J,358.3,5243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5243,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,5243,1,5,0)
 ;;=5^Headache,Cluster NOS
 ;;^UTILITY(U,$J,358.3,5243,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,5244,0)
 ;;=339.01^^41^483^42
 ;;^UTILITY(U,$J,358.3,5244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5244,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,5244,1,5,0)
 ;;=5^Headache,Cluster Episodic
 ;;^UTILITY(U,$J,358.3,5244,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,5245,0)
 ;;=339.02^^41^483^41
 ;;^UTILITY(U,$J,358.3,5245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5245,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,5245,1,5,0)
 ;;=5^Headache,Cluster Chronic
 ;;^UTILITY(U,$J,358.3,5245,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,5246,0)
 ;;=339.03^^41^483^65
 ;;^UTILITY(U,$J,358.3,5246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5246,1,4,0)
 ;;=4^339.03
 ;;^UTILITY(U,$J,358.3,5246,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Episodic
 ;;^UTILITY(U,$J,358.3,5246,2)
 ;;=^336547
 ;;^UTILITY(U,$J,358.3,5247,0)
 ;;=339.04^^41^483^64
 ;;^UTILITY(U,$J,358.3,5247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5247,1,4,0)
 ;;=4^339.04
 ;;^UTILITY(U,$J,358.3,5247,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Chr
 ;;^UTILITY(U,$J,358.3,5247,2)
 ;;=^336548
 ;;^UTILITY(U,$J,358.3,5248,0)
 ;;=339.05^^41^483^57
 ;;^UTILITY(U,$J,358.3,5248,1,0)
 ;;=^358.31IA^5^2
